CardIQ Suite
by GE Medical Systems SCS
· Based in United States →
— An integrated suite of CT Cardiac post-processing tools, built for automation and workflow efficiency.
Contact for pricing
Regulatory Status Disclosed
Overview
CardIQ Suite, developed by GE Medical Systems SCS (a GE HealthCare company), is a comprehensive post-processing application designed for advanced cardiac image analysis. It provides an integrated workflow for seamlessly reviewing calcium scoring and Coronary CT Angiography (CCTA) data. The tool leverages deep learning models for automated calcium scoring, identifying coronary calcium burden and location, and providing total and per-territory scores rapidly. It also facilitates CCTA 2D review, including cine capability for motion studies and double oblique tools for detailed visualization of coronary arteries and chambers. CardIQ Suite is intended to aid in the diagnosis and determination of treatment paths for various cardiovascular diseases by analyzing 2D or 3D CT cardiac non-contrast and angiography DICOM data.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Deep Learning based automated Calcium Score and labeling of coronary artery territories
- Integrated workflow for seamless review of calcium scoring and CCTA data
- CCTA 2D Review with cine capability for motion studies and chamber mobility analysis
- Double oblique tools for detailed visualization of coronary vasculature
- Measurement tools for distance and Region of Interest (ROI) generation
- Ability to assign calcifications to individual coronary artery branches
- Ability to score and label calcifications found in the aorta and cardiac valves
- Plaque ID tool for visualizing and quantifying plaque burden (CardIQ Xpress 2.0 Reveal)
- Relative perfusion analysis for highlighting and quantifying hypo-dense myocardial areas (CardIQ Xpress 2.0 Reveal)
- Automated segmentation and labeling of calcifications within coronary arteries
Use Cases
- Evaluation and diagnosis of coronary artery disease
- Qualitative and quantitative assessment of heart anatomy and coronary artery vessels from CT images
- Monitoring the progression or regression of calcium in coronary arteries over time
- Aiding in the prognosis of cardiac disease
- Follow-up for stent placement, bypasses, and plaque imaging
- Functional assessment of left and right ventricular volumes, ejection fractions, and myocardial mass (with CardIQ Function Xpress)
What Physicians Need to Know
ECG/EKG Analysis Capability
Not specified for CardIQ Suite. The tool focuses on CT cardiac post-processing.
Echocardiography AI Features
Not specified for CardIQ Suite. GE HealthCare offers separate AI solutions like ViewPoint EchoPilot for echocardiography.
Cardiac CT/MRI Analysis
CardIQ Suite is an integrated suite of CT Cardiac post-processing tools. It analyzes 2D/3D CT cardiac non-contrast and angiography DICOM data, providing visualization and measurement of vessels and chamber mobility. It aids in diagnosing and determining treatment paths for cardiovascular diseases, including coronary artery disease, functional heart parameters, heart structures, and follow-up for stents, bypasses, and plaque imaging.
Arrhythmia Detection Accuracy
Not specified for CardIQ Suite. The tool's primary function is not arrhythmia detection.
Heart Failure Risk Prediction
The suite includes the ability to visualize and estimate the volume of heart fat. This data, along with calcium scoring, can be leveraged for heart failure risk assessment, as CTCS-based models combining calcium and fat-omics have shown promise in predicting incident heart failure.
Coronary Artery Assessment
Provides an integrated workflow for reviewing calcium scoring and CCTA data. Features a fully automated, deep learning-based calcium scoring algorithm that identifies coronary calcium burden and location, delivering total and per-territory scores rapidly. It automatically labels coronary artery territories and segments calcifications, including those in the aorta and cardiac valves. Offers CCTA 2D review with cine capability for motion studies and oblique tools for vascular visualization.
Cardiac Monitoring Integration
Not specified for CardIQ Suite. The tool focuses on post-processing of CT imaging data.
AHA/ACC Guideline Alignment
The integrated workflow for calcium scoring and CCTA data review aligns with guidelines such as the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease and the CAC-DRS (Coronary Artery Calcium Data and Reporting System).
Real-Time Alert Capability
Not specified for CardIQ Suite. The tool's function is primarily post-processing and analysis rather than real-time alerts.
Physician Tip
Leverage CardIQ Suite's deep learning-based automated calcium scoring and comprehensive CCTA review for efficient and accurate diagnosis of coronary artery disease and assessment of cardiac structures. Utilize the integrated workflow to streamline image analysis and reduce manual steps, enhancing productivity. Pay attention to the heart fat volume estimation, as it provides additional data points for a broader cardiovascular risk assessment, particularly for heart failure prediction. The ability to visualize chamber mobility and follow up on interventions like stents and bypasses can significantly aid in treatment planning and patient management.
CardIQ Suite is part of GE HealthCare's AW Family Advanced Visualization applications. GE HealthCare is actively working towards seamless integration of its AW Family applications, including CardIQ Suite, with third-party enterprise imaging diagnostic applications like Sectra's, to create unified platforms. This aims to enhance clinical efficiency, reduce system switching, and streamline cardiology workflows, potentially leading to faster workflows and increased productivity.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing | Contact for pricing |
| Deployment | On-premise (GE Advantage Workstation (AW) and AW Server (AWS)) |
| Compliance | |
| BAA Available | Yes AI-estimated |
| HIPAA Compliant | Yes AI-estimated |
| FDA Status |
1 AI-estimated CardIQ Suite (K243672) received FDA 510(k) clearance on June 18, 2025. It is a non-invasive software application for analyzing cardiovascular anatomy and pathology from 2D or 3D CT cardiac non-contrast and angiography DICOM data, providing visualization, measurement of vessels and chamber mobility, and calcium scoring to aid in the diagnosis and treatment planning of cardiovascular diseases. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Radiology |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate CardIQ Suite
Press & Coverage
GE HealthCare
GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
GE HealthCare introduced its latest suite of cardiology innovations, including CardIQ Suite, at the European Society of Cardiology (ESC) Congress 2025, focusing on enhancing clinical decision-making and workflow efficiency. CardIQ Suite is a comprehensive post-processing application for advanced cardiac image analysis, featuring a fully automated calcium scoring algorithm and the ability to visualize heart fat.
2025-08
GE HealthCare
ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
GE HealthCare announced the U.S. launch of innovations at ACC 2025, with CardIQ Suite highlighted as an integrated workflow for seamless review of calcium scoring and cardiac CT angiography (CCTA) data. The suite includes an automated calcium scoring algorithm and tools for visualizing heart fat.
2025-03
24x7 Magazine
GE HealthCare Showcases Newly CE-Marked AI-Powered Cardiology Systems - 24x7
Ahead of ESC 2025, GE HealthCare introduced new CE-marked AI-powered cardiology innovations, including CardIQ Suite, designed to streamline cardiac workflows and improve diagnostic confidence. CardIQ Suite is described as a post-processing application for advanced cardiac image analysis with an automated calcium scoring algorithm.
2025-08
Imaging Technology News
GE HealthCare and Sectra Plan to Leverage Deep Integration to Help Enhance Clinical Efficiency | Imaging Technology News
In November 2023, GE HealthCare and Sectra announced plans for deep integration of GE HealthCare's 'AW Family' Advanced Visualization applications, starting with CardIQ Suite, into Sectra's enterprise imaging diagnostic application for radiology. This collaboration aims to enhance clinical efficiency and streamline cardiology workflows.
2023-11
FirstWord HealthTech
ESC25: GE HealthCare highlights AI cardiology tech aimed at earlier, accurate diagnoses
At ESC 2025, GE HealthCare presented AI-powered cardiology products cleared in Europe, including CardIQ Suite, which uses deep learning to automate CT cardiac post-processing calcium scoring with high accuracy. The software also integrates with CCTA review for chamber motion analysis and advanced rendering.
2025-08
ResearchGate
408 Evaluation Of A Deep Learning Based Fully Automated Coronary Calcium Scoring Algorithm, CardIQ Suite Software | Request PDF - ResearchGate
A July 2022 publication in the Journal of Cardiovascular Computed Tomography details the evaluation of a deep learning-based fully automated coronary calcium scoring algorithm within the CardIQ Suite Software. The study highlights the system's ability to automatically quantify coronary calcium on routine cardiac-gated and non-gated CT scans.
2022-07
FDA
GE Medical Systems SCS Mireille Haddad Regulatory Affairs Program Manager 283, rue de la Miniere BUC, 78530 FR - accessdata.fda.gov
An FDA 510(k) premarket notification from June 2025 details CardIQ Suite's indications for use, including the analysis of cardiovascular anatomy and pathology from 2D or 3D CT cardiac data. It provides capabilities for visualization and measurement of vessels and chamber mobility, aiding in diagnosis and treatment path determination for cardiovascular diseases.
2025-06
MDPI (Journal of Clinical Medicine)
Machine Learning-Enabled Medical Devices Authorized by the US Food and Drug Administration in 2024: Regulatory Characteristics, Predicate Lineage, and Transparency Reporting - MDPI
A December 2025 article in the International Journal of Medical Devices lists CardIQ Suite (K233731) as a machine learning-enabled medical device authorized by the FDA in 2024. It is categorized under cardiac imaging and analysis, utilizing deep learning technology.
2025-12
Videos
Product demos, reviews, and walkthroughs for CardIQ Suite.
No videos found. Search YouTube directly
Frequently Asked Questions
CardIQ Suite employs deep learning algorithms to automate and enhance the review of cardiac CT data, including calcium scoring and Coronary CT Angiography (CCTA). It automatically identifies coronary calcium burden, labels coronary artery territories, and segments calcifications to provide total and per-territory scores within seconds. This automation aims to streamline workflows and improve efficiency in diagnosing coronary artery disease.
CardIQ Suite has received FDA clearance as a non-invasive software application intended to analyze CT cardiovascular anatomy and pathology and aid in determining treatment paths. It is designed and manufactured under Quality System Regulations (21 CFR Part 820 and ISO 13485) and complies with NEMA PS 3.1 - 3.20 (DICOM) standards for medical imaging interoperability.
While CardIQ Suite offers significant automation and efficiency, it is a software application intended to aid in diagnosis and should not replace clinical judgment. The responsibility to analyze application requirements and integrate GE imaging equipment with non-GE systems lies with the user. Physicians should also be aware that, like all AI tools, it is a diagnostic aid and not a definitive diagnostic tool on its own.
Yes, the market for AI in medical imaging is growing, with several platforms offering similar or complementary capabilities in cardiology. Alternatives include solutions from companies like Aidoc, Viz.ai, Tempus AI, and INFINITT Cardiology Suite, which provide AI-driven analysis for various cardiac conditions and imaging modalities. These platforms often focus on enhancing diagnostic accuracy, streamlining workflows, and enabling early disease detection.
Specific public pricing for CardIQ Suite is not readily available, as is common for enterprise healthcare software solutions. However, an older version, CardIQ Xpress, was noted to average around $30,000, and pricing can vary based on package deals, whether it's a standalone solution, or an upgrade. Generally, AI medical imaging tools may involve custom quotes for larger deployments, with some alternatives offering subscription models.
CardIQ Suite is designed to provide an integrated workflow for reviewing calcium scoring and CCTA data, working with DICOM CT data acquisitions. It can be integrated with GE's Advantage Workstation (AW) and AW Server platforms, and GE HealthCare is also integrating its AW Family Advanced Visualization applications, including CardIQ Suite, with Sectra's enterprise imaging diagnostic application to create a unified platform. This integration aims to reduce the number of systems needed and streamline the workflow for radiologists.
CardIQ Suite's deep learning models for automated calcium scoring have demonstrated high consistency and accuracy. It shows >90% concordance with CACS-DRS classification grouping, >95% correct identification of coronary artery calcifications, and >90% accurately labeled coronary artery territories. These models were developed and trained using diverse clinical datasets from a global population, spanning multiple scanner types and vendors.
Compare CardIQ Suite
VS
CardIQ Suite vs Biograph Vision.X and Biograph Vision.X Edge
CardIQ Suite is a software application for cardiac CT post-processing, specializing in automated calcium scoring and CCTA review for cardiovascular disease diagnosis. In contrast, Biograph Vision.X and Biograph…
VS
CardIQ Suite vs Digital Color Doppler Ultrasound System (P60 Series)
CardIQ Suite is a CT post-processing software focused on detailed cardiovascular analysis, including calcium scoring and CCTA review. In contrast, the Sonoscape P60 Series is a comprehensive ultrasound…
VS
CardIQ Suite vs EchoNext
CardIQ Suite and EchoNext are adjacent tools in cardiology AI, both aiding in heart disease diagnosis but with distinct approaches. CardIQ Suite focuses on post-processing cardiac CT scans…
VS
CardIQ Suite vs VX1
CardIQ Suite focuses on pre-procedural cardiac CT analysis for diagnosis and treatment planning, offering automated calcium scoring and CCTA review. In contrast, VX1 is an intra-procedural AI tool…
Suggest an Edit →
| Last Verified: 2026-04-18 | First Added: 2026-04-18